CLEC2A

Chr 12

C-type lectin domain family 2 member A

Also known as: INPE5792, KACL, PILAR, UNQ5792

CLEC2A encodes a membrane-bound protein expressed on keratinocytes that serves as a ligand for the NKp65 receptor on natural killer cells, facilitating immune recognition and NK cell-mediated cytotoxicity while also modulating T-cell expansion. The gene shows extremely high constraint against loss-of-function variants (pLI = 1.0, LOEUF = 1.841), suggesting that haploinsufficiency would likely be pathogenic, but no specific Mendelian diseases have been definitively associated with CLEC2A mutations to date.

Summary from RefSeq, UniProt
Research Assistant →
0
Active trials
0
Pubs (1 yr)
36
P/LP submissions
0%
P/LP missense
1.84
LOEUF
Multiple*
Mechanism· predicted
Clinical SummaryCLEC2A
Population Constraint (gnomAD)
Low constraint (pLI 0.00) — loss-of-function variants are relatively tolerated in the population.
📋
ClinVar Variants
36 unique Pathogenic / Likely Pathogenic· 64 VUS of 107 total submissions

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Tolerant — LoF & missense variants common in population
LoF Constraint
1.84LOEUF
pLI 0.000
Z-score -0.40
OE 1.17 (0.671.84)
Tolerant

Highly tolerant — LoF variants common in population

Missense Constraint
0.66Z-score
OE missense 0.80 (0.650.98)
65 obs / 81.7 exp
Tolerant

Mild missense constraint

Observed / Expected Ratios
LoF OE1.17 (0.671.84)
00.351.4
Missense OE0.80 (0.650.98)
00.61.4
Synonymous OE0.81
01.21.6
LoF obs/exp: 8 / 6.9Missense obs/exp: 65 / 81.7Syn Z: 0.74
DN
0.86top 5%
GOF
0.73top 25%
LOF
0.1498th %ile

This gene has evidence for multiple mechanisms of pathogenicity (dominant-negative and gain-of-function). Both the Badonyi & Marsh prediction and the broader genomic evidence point to dominant-negative as the predominant mechanism. Different variants in this gene may act through different mechanisms — interpret in context of the specific variant.

DNprediction above median
GOFprediction above median

Note: In-silico variant effect predictors (SIFT, PolyPhen, REVEL, CADD) may underestimate pathogenicity of missense variants in genes with GOF or DN mechanisms. Consider functional evidence and clinical context.

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312.

ClinVar Variant Classifications

107 submitted variants in ClinVar

Classification Summary

Pathogenic34
Likely Pathogenic2
VUS64
Likely Benign4
34
Pathogenic
2
Likely Pathogenic
64
VUS
4
Likely Benign

Curated Variants Distribution

Classified variants from ClinVar · 5 ACMG categories

ClassificationLoFMissense + InframeNon-codingSynonymousTotal
Pathogenic
0
0
34
0
34
Likely Pathogenic
0
0
2
0
2
VUS
0
59
5
0
64
Likely Benign
0
3
1
0
4
Benign
0
0
0
0
0
Total062420104

LoF = frameshift, stop gained/lost, canonical splice · Counts from ClinVar esearch · Updated hourly

View in ClinVar →

Protein Context — Lollipop Plot

CLEC2A · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →
Clinical Literature
Open Research Assistant →
Full-Text Mentions
NLP-detected gene mentions in article bodies · via PubTator3
PubTator3
Top 5 full-text resultsSearch PubTator3 ↗
Key Publications
Landmark & review papers · by relevance
PubMed
Top 1 results · since 2015Search PubMed ↗